# Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals

> clinical trial · VERIFIED · 2026-07-17

Status: NOT_YET_RECRUITING · Sponsor: Mei Gao · Condition: Hyperlipidemia

- Company: Mei Gao
- Sector: Hyperlipidemia
- Primary source: https://clinicaltrials.gov/study/NCT07712042

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.